Key Updates in Gastric and Esophageal Cancer Management / cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

Indocyanine green may be highly sensitive in the identification of ovarian cancer metastases, though with low specificity. One method used for intraoperative tissue imaging is indocyanine green (ICG).

An exploratory 100-patient study found that a leakage-free Random Forest poorly classified post-treatment NGAL decline and ...

Background The role of intrinsic tumour heterogeneity in driving organ-tropic metastasis in gastric cancer remains ...

Mabwell presented Phase II clinical data on its Nectin-4-targeting antibody-drug conjugate (ADC) 9MW2821 (Bulumtatug Fuvedotin, "BFv") in locally advanced or metastatic triple-negative breast cancer ...

When cervical cancer returns or spreads after initial treatment, the outlook is often measured in months rather than years.

SHANGHAI, Oct. 19, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical data on its ...

Positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after first 12 weeks of treatment Optional ...

A peer-reviewed study validates Gnosis' EdenDx cervical sample test, showing 96.8% specificity for endometrial cancer ...

ORANGE, CA / ACCESS Newswire / October 15, 2026 / Unlike most cancers, endometrial cancer is rising in incidence and ...

Elevar Therapeutics, Inc., a biopharmaceutical company and a majority-owned subsidiary of HLB Co., Ltd. (028300.KQ), announced that it resubmitted a New Drug Application (NDA) to the U.S. Food and ...